The Occupational Burden of Nonmalignant Respiratory Diseases. An Official American Thoracic Society and European Respiratory Society Statement

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review

Standard

The Occupational Burden of Nonmalignant Respiratory Diseases. An Official American Thoracic Society and European Respiratory Society Statement. / Blanc, Paul D.; Redlich, Carrie A.; Annesi-Maesano, Isabella; Balmes, John R.; Cummings, Kristin J.; Fishwick, David; Miedinger, David; Murgia, Nicola; Naidoo, Rajen N.; Reynolds, Carl J.; Sigsgaard, Torben; Torén, Kjell; Vinnikov, Denis.

I: American Journal of Respiratory and Critical Care Medicine, Bind 199, Nr. 11, 06.2019, s. 1312-1334.

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review

Harvard

Blanc, PD, Redlich, CA, Annesi-Maesano, I, Balmes, JR, Cummings, KJ, Fishwick, D, Miedinger, D, Murgia, N, Naidoo, RN, Reynolds, CJ, Sigsgaard, T, Torén, K & Vinnikov, D 2019, 'The Occupational Burden of Nonmalignant Respiratory Diseases. An Official American Thoracic Society and European Respiratory Society Statement', American Journal of Respiratory and Critical Care Medicine, bind 199, nr. 11, s. 1312-1334. https://doi.org/10.1164/rccm.201904-0717ST

APA

Blanc, P. D., Redlich, C. A., Annesi-Maesano, I., Balmes, J. R., Cummings, K. J., Fishwick, D., Miedinger, D., Murgia, N., Naidoo, R. N., Reynolds, C. J., Sigsgaard, T., Torén, K., & Vinnikov, D. (2019). The Occupational Burden of Nonmalignant Respiratory Diseases. An Official American Thoracic Society and European Respiratory Society Statement. American Journal of Respiratory and Critical Care Medicine, 199(11), 1312-1334. https://doi.org/10.1164/rccm.201904-0717ST

CBE

Blanc PD, Redlich CA, Annesi-Maesano I, Balmes JR, Cummings KJ, Fishwick D, Miedinger D, Murgia N, Naidoo RN, Reynolds CJ, Sigsgaard T, Torén K, Vinnikov D. 2019. The Occupational Burden of Nonmalignant Respiratory Diseases. An Official American Thoracic Society and European Respiratory Society Statement. American Journal of Respiratory and Critical Care Medicine. 199(11):1312-1334. https://doi.org/10.1164/rccm.201904-0717ST

MLA

Vancouver

Blanc PD, Redlich CA, Annesi-Maesano I, Balmes JR, Cummings KJ, Fishwick D o.a. The Occupational Burden of Nonmalignant Respiratory Diseases. An Official American Thoracic Society and European Respiratory Society Statement. American Journal of Respiratory and Critical Care Medicine. 2019 jun;199(11):1312-1334. https://doi.org/10.1164/rccm.201904-0717ST

Author

Blanc, Paul D. ; Redlich, Carrie A. ; Annesi-Maesano, Isabella ; Balmes, John R. ; Cummings, Kristin J. ; Fishwick, David ; Miedinger, David ; Murgia, Nicola ; Naidoo, Rajen N. ; Reynolds, Carl J. ; Sigsgaard, Torben ; Torén, Kjell ; Vinnikov, Denis. / The Occupational Burden of Nonmalignant Respiratory Diseases. An Official American Thoracic Society and European Respiratory Society Statement. I: American Journal of Respiratory and Critical Care Medicine. 2019 ; Bind 199, Nr. 11. s. 1312-1334.

Bibtex

@article{6bad666f43304622a34bfe9ec4448e28,
title = "The Occupational Burden of Nonmalignant Respiratory Diseases. An Official American Thoracic Society and European Respiratory Society Statement",
abstract = "Rationale: Workplace inhalational hazards remain common worldwide, even though they are ameliorable. Previous American Thoracic Society documents have assessed the contribution of workplace exposures to asthma and chronic obstructive pulmonary disease on a population level, but not to other chronic respiratory diseases. The goal of this document is to report an in-depth literature review and data synthesis of the occupational contribution to the burden of the major nonmalignant respiratory diseases, including airway diseases; interstitial fibrosis; hypersensitivity pneumonitis; other noninfectious granulomatous lung diseases, including sarcoidosis; and selected respiratory infections. Methods: Relevant literature was identified for each respiratory condition. The occupational population attributable fraction (PAF) was estimated for those conditions for which there were sufficient population-based studies to allow pooled estimates. For the other conditions, the occupational burden of disease was estimated on the basis of attribution in case series, incidence rate ratios, or attributable fraction within an exposed group. Results: Workplace exposures contribute substantially to the burden of multiple chronic respiratory diseases, including asthma (PAF, 16%); chronic obstructive pulmonary disease (PAF, 14%); chronic bronchitis (PAF, 13%); idiopathic pulmonary fibrosis (PAF, 26%); hypersensitivity pneumonitis (occupational burden, 19%); other granulomatous diseases, including sarcoidosis (occupational burden, 30%); pulmonary alveolar proteinosis (occupational burden, 29%); tuberculosis (occupational burden, 2.3% in silica-exposed workers and 1% in healthcare workers); and community-acquired pneumonia in working-age adults (PAF, 10%). Conclusions: Workplace exposures contribute to the burden of disease across a range of nonmalignant lung conditions in adults (in addition to the 100% burden for the classic occupational pneumoconioses). This burden has important clinical, research, and policy implications. There is a pressing need to improve clinical recognition and public health awareness of the contribution of occupational factors across a range of nonmalignant respiratory diseases.",
keywords = "Interstitial fibrosis, Nonmalignant respiratory diseases, Occupational, Pneumonitis, Respiratory infections, Sarcoidosis, Workplace",
author = "Blanc, {Paul D.} and Redlich, {Carrie A.} and Isabella Annesi-Maesano and Balmes, {John R.} and Cummings, {Kristin J.} and David Fishwick and David Miedinger and Nicola Murgia and Naidoo, {Rajen N.} and Reynolds, {Carl J.} and Torben Sigsgaard and Kjell Tor{\'e}n and Denis Vinnikov",
year = "2019",
month = jun,
doi = "10.1164/rccm.201904-0717ST",
language = "English",
volume = "199",
pages = "1312--1334",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society",
number = "11",

}

RIS

TY - JOUR

T1 - The Occupational Burden of Nonmalignant Respiratory Diseases. An Official American Thoracic Society and European Respiratory Society Statement

AU - Blanc, Paul D.

AU - Redlich, Carrie A.

AU - Annesi-Maesano, Isabella

AU - Balmes, John R.

AU - Cummings, Kristin J.

AU - Fishwick, David

AU - Miedinger, David

AU - Murgia, Nicola

AU - Naidoo, Rajen N.

AU - Reynolds, Carl J.

AU - Sigsgaard, Torben

AU - Torén, Kjell

AU - Vinnikov, Denis

PY - 2019/6

Y1 - 2019/6

N2 - Rationale: Workplace inhalational hazards remain common worldwide, even though they are ameliorable. Previous American Thoracic Society documents have assessed the contribution of workplace exposures to asthma and chronic obstructive pulmonary disease on a population level, but not to other chronic respiratory diseases. The goal of this document is to report an in-depth literature review and data synthesis of the occupational contribution to the burden of the major nonmalignant respiratory diseases, including airway diseases; interstitial fibrosis; hypersensitivity pneumonitis; other noninfectious granulomatous lung diseases, including sarcoidosis; and selected respiratory infections. Methods: Relevant literature was identified for each respiratory condition. The occupational population attributable fraction (PAF) was estimated for those conditions for which there were sufficient population-based studies to allow pooled estimates. For the other conditions, the occupational burden of disease was estimated on the basis of attribution in case series, incidence rate ratios, or attributable fraction within an exposed group. Results: Workplace exposures contribute substantially to the burden of multiple chronic respiratory diseases, including asthma (PAF, 16%); chronic obstructive pulmonary disease (PAF, 14%); chronic bronchitis (PAF, 13%); idiopathic pulmonary fibrosis (PAF, 26%); hypersensitivity pneumonitis (occupational burden, 19%); other granulomatous diseases, including sarcoidosis (occupational burden, 30%); pulmonary alveolar proteinosis (occupational burden, 29%); tuberculosis (occupational burden, 2.3% in silica-exposed workers and 1% in healthcare workers); and community-acquired pneumonia in working-age adults (PAF, 10%). Conclusions: Workplace exposures contribute to the burden of disease across a range of nonmalignant lung conditions in adults (in addition to the 100% burden for the classic occupational pneumoconioses). This burden has important clinical, research, and policy implications. There is a pressing need to improve clinical recognition and public health awareness of the contribution of occupational factors across a range of nonmalignant respiratory diseases.

AB - Rationale: Workplace inhalational hazards remain common worldwide, even though they are ameliorable. Previous American Thoracic Society documents have assessed the contribution of workplace exposures to asthma and chronic obstructive pulmonary disease on a population level, but not to other chronic respiratory diseases. The goal of this document is to report an in-depth literature review and data synthesis of the occupational contribution to the burden of the major nonmalignant respiratory diseases, including airway diseases; interstitial fibrosis; hypersensitivity pneumonitis; other noninfectious granulomatous lung diseases, including sarcoidosis; and selected respiratory infections. Methods: Relevant literature was identified for each respiratory condition. The occupational population attributable fraction (PAF) was estimated for those conditions for which there were sufficient population-based studies to allow pooled estimates. For the other conditions, the occupational burden of disease was estimated on the basis of attribution in case series, incidence rate ratios, or attributable fraction within an exposed group. Results: Workplace exposures contribute substantially to the burden of multiple chronic respiratory diseases, including asthma (PAF, 16%); chronic obstructive pulmonary disease (PAF, 14%); chronic bronchitis (PAF, 13%); idiopathic pulmonary fibrosis (PAF, 26%); hypersensitivity pneumonitis (occupational burden, 19%); other granulomatous diseases, including sarcoidosis (occupational burden, 30%); pulmonary alveolar proteinosis (occupational burden, 29%); tuberculosis (occupational burden, 2.3% in silica-exposed workers and 1% in healthcare workers); and community-acquired pneumonia in working-age adults (PAF, 10%). Conclusions: Workplace exposures contribute to the burden of disease across a range of nonmalignant lung conditions in adults (in addition to the 100% burden for the classic occupational pneumoconioses). This burden has important clinical, research, and policy implications. There is a pressing need to improve clinical recognition and public health awareness of the contribution of occupational factors across a range of nonmalignant respiratory diseases.

KW - Interstitial fibrosis

KW - Nonmalignant respiratory diseases

KW - Occupational

KW - Pneumonitis

KW - Respiratory infections

KW - Sarcoidosis

KW - Workplace

U2 - 10.1164/rccm.201904-0717ST

DO - 10.1164/rccm.201904-0717ST

M3 - Journal article

C2 - 31149852

AN - SCOPUS:85066829374

VL - 199

SP - 1312

EP - 1334

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

SN - 1073-449X

IS - 11

ER -